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Abstract
Objectives: To investigate the effects of topical agents for the treatment of Myofascial Pain Syndrome (MPS) and
Myofascial Trigger Point (MTRP).
Methods: Subjects with an identifiable trigger point in the trapezius muscle, age 18-80 were recruited for a single-
session randomized, placebo-blinded clinical study. Baseline measurements of trapezius muscle pressure pain
threshold (PPT: by pressure algometer) along with right and left cervical lateral flexion (rangiometer) were obtained
by a blinded examiner. An assessor blinded to the outcomes assessments applied one of 6 topical formulations
which had been placed in identical plastic containers. Five of these topicals were proposed active formulations; the
control group was given a non-active formulation (PLA). Five minutes after the application of the formula the
outcome measures were re-tested. Data were analyzed with a 5-way ANOVA and Holms-adjusted t-tests with an
alpha level of 0.05.
Results: 120 subjects were entered into the study (63 females; ages 16-82); 20 subjects randomly allocated into each
group. The pre- and post-treatment results for pressure threshold did show significant intra-group increases for the Ben-
Gay Ultra Strength Muscle Pain Ointment (BG), the Professional Therapy MuscleCare Roll-on (PTMC roll-on) and Motion
Medicine Cream (MM) with an increased threshold of 0.5 kg/cm
2 (+/-0.15), 0.72 kg/cm
2 (+/-0.17) and 0.47 Kg/cm
2
(+/-0.19) respectively. With respect to the inter-group comparisons, PTMC roll-on showed significant increases in
pressure threshold compared with Placebo (PLA) (p = 0.002) and Icy Hot Extra Strength Cream (IH) (p = 0.006). In
addition, BG demonstrated significant increases in pressure threshold compared with PLA (p = 0.0003).
Conclusions: With regards to pressure threshold, PTMC roll-on, BG and MM showed significant increases in pain
threshold tolerance after a short-term application on a trigger points located in the trapezius muscle. PTMC roll-on
and BG were both shown to be superior vs placebo while PTMC was also shown to be superior to IH in patients
with trigger points located in the trapezius muscle on a single application.
CMCC Research Ethics Board Approval # 1012X01, 2011
Introduction
Myofascial Pain Syndrome (MPS) is exceedingly com-
mon in Western society [1-3]. Vernon and Schneider
note that MPS is thought to be the leading diagnosis
among pain management specialists [4,5] and the lead-
ing diagnosis in pain patients reporting to general
practitioners [4,6]. MPS can be viewed as a regional
pain syndrome such as, neck, low back and upper quad-
rant pain syndromes. MPS can also be found focally in
discrete painful sites known as Myofascial Trigger Point
(MTrP). Locations of MTrP’s have been characterized
on clinical grounds throughout the musculoskeletal sys-
tem, starting with the seminal work of Travell and
Simons [6,7]. MTrP’s have been described as active
(clinically active with pain referral upon palpation) or
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tion) [7-9]. The presence of associated features such as
“local twitch sign” and palpable taut bands is thought to
confirm the presence of an active MTrP, while latent
TP’s may not present with the classic features.
Numerous treatments are currently available for MPS
and MTrP’s. Several systematic reviews have recently
been published on a variety of treatments [4,10-14],
including pharmacologic agents, physical agents, com-
plementary and alternative therapies. One commonly
used therapy is the application of topical agents to
relieve pain [15-17]. These agents can be classified as
pharmacologic or non-pharmacologic. The former cate-
gory includes non-steroidal anti-inflammatory agents
(such as ketaprofen), opioid agents, classical analgesic
agents (such as lidocaine), novel analgesic agents such
as capsaicin and rubefascient agents (containing salicy-
lates or nicotinamides) [15-17]. Non-pharmacologic
agents generally fall into the complementary and alter-
native medicine (CAM) category for MPS and MTrP
treatments. They may contain putative analgesic agents
or counterirritant agents and they may exert cold, hot
or neutral effects.
Several studies have investigated the effect of such
topicals in the treatment of osteoarthritis, particularly of
the knee [18,19]. However, there appears to be a lack of
studies investigating the effects of topical agents for the
treatment of MPS or MTrP. A randomized, placebo-
blinded clinical trial of non-pharmacological topical
analgesics was conducted comparing leading national
and professional brands in the treatment of a myofascial
trigger point.
Materials and methods
Subjects
Subjects were selected from consecutive clinical presen-
tations of patients for treatment in a multidisciplinary
health clinic. Subjects aged 18-80, male or female, with
or without neck pain were included. Subjects were
excluded for the following reasons: acute pain presenta-
tion preventing comfortable participation and absence of
a palpable tender spot in the right upper trapezius
region. Subjects were informed of the nature of the
experiment and consented to participate. This protocol
was approved by the Research Ethics Board of the Cana-
dian Memorial Chiropractic College.
Randomization
A random number sequence was generated by an inde-
pendent party and kept in the care of the clinic adminis-
trator until required for subject allocation. The
randomization schedule was concealed from all other
study staff prior to selection and prior to group
allocation.
Outcome measures
Pre- and post-intervention measures consisted of 1) ten-
derness at an MTrP in the upper trapezius and, 2) right
and left cervical spine lateral flexion. Tenderness was
measured using a manual pressure algometer and was
reported in kg/cm
2 [20]. Once identified by palpation
and marked on the skin, the MTrP was subjected to
vertical pressure with the pressure algometer at the rate
o f1k g / c m
2 per second. The subject was instructed to
indicate verbally when the first instance of tenderness
was felt. A single trial was used. Right and left cervical
spine lateral flexions were measured using a cervical
rangiometer [21] and were reported in degrees. A single
trial was used. Both measures have proven reliable and
valid in the assessment of MTrP’s [9,21-27]. Following
the intervention, subjects were asked to rate their level
of satisfaction on a verbal satisfaction scale (P = poor, F
= fair, G = good, E = excellent).
Interventions
Six topical products were tested: three were ointments,
two were roll-on gels and one a non-medicinal placebo
cream (PLA) which served as the control. The compara-
tive topicals were Professional Therapy MuscleCare
Roll-on
a (PTMC roll-on), Motion Medicine cream
b
(MM cream), Bengay Ultra Strength Muscle Pain oint-
ment
c (BG), Icy Hot Extra Strength Cream
d (IH), and
Biofreeze roll-on gel
e (BF). All of these products were
placed in identical 0.5 ounce white plastic screw top
containers or 3 ounce generic white roll-on bottles.
Only a coded letter was applied as a label. The master
code for these products was kept with the clinic admin-
istrator and was unknown to all study participants and
assessors.
Procedures
Subjects were seated erect in a comfortable ergonomic
chair in a private room. Subjects wore a nose clip for
the entire duration of the study so they could not smell
any of the scents from the topical analgesics. Subjects
were not allowed to view the application of the topical
analgesics and they were not permitted to look at their
shoulder during the entire process. Assessor #1 entered
the room and palpated the subject’s right shoulder in
order to determine the presence and location of an
MTrP in the upper trapezius muscle adjacent to the 7
th
cervical vertebrae and the 1
st thoracic vertebrae. This
was marked with a black dot. Assessor #1 exited the
room and assessor #2 entered and performed the base-
line testing of the outcome measures (Figure 1). The
rangiometer was placed on the subject’sh e a d .F r o ma
neutral position, right and left active end-range lateral
flexion measurements were recorded. The pressure alg-
ometer was applied over the marked trapezius trigger
Avrahami et al. Chiropractic & Manual Therapies 2012, 20:7
http://chiromt.com/content/20/1/7
Page 2 of 6point for the baseline pressure reading. The subject was
instructed to indicate when the pressure point was
painful.
Following the initial outcome measurements, assessor
#1 re-entered the room and applied one of the six sam-
ples according to the randomization schedule which was
revealed only at that time in the area of the marked
pressure point (Figure 1). The subject was instructed to
stay seated in the chair with little head movement for
five to seven minutes, following which, assessor #2 reas-
sessed and recorded the pain and range of motion out-
come measures. The study was conducted over a 7-day
period.
Analyses
Data were first analyzed descriptively–baseline, post-
intervention and change scores. Change scores for each
of the three measurements (Pressure pain threshold,
Right and Left lateral flexion) were analyzed using a 5-
way ANOVA. Statistically significant ANOVA’s( p>
0.05) were then subjected to multiple t-tests with
Holm’s adjustment of the p-value. As such, the alpha
levels were set at 0.007.
Results
120 subjects were entered into the study, 20 in each
group (63 females; ages 18-80). Fifty-six percent (56%)
of patients presented with clinical shoulder or neck
pain. Group demographics and clinical baseline values
can be found in Table 1. There were no significant dif-
ferences regarding group demographics and clinical
baseline values.
The pre- and post-treatment results for pressure
threshold are displayed in Table 2. ANOVA for inter-
group differences was significant (F = 5.2, p = 0.002).
Significant intra-group increases for BG, PTMC roll-on
and MM cream were obtained with an increased thresh-
old of 0.5 kg/cm
2 (+/-0.15), 0.72 kg/cm
2 (+/-0.17) and
0.47 Kg/cm
2 (+/-0.19) respectively.
With respect to the inter-group comparisons, PTMC
roll-on showed significant increases in pressure thresh-
old compared with PLA (p = 0.002) and IH (p = 0.006).
In addition, BG demonstrated significant increases in
pressure threshold compared with PLA (p = 0.0003).
The pre- and post-treatment results for right and left
lateral flexion did not show significant increases in range
of motion for any of the topical analgesics (Table 3).
Patient satisfaction ratings were high in each group
and there were no significant differences between
groups. There were no adverse reactions or complaints
of pain aggravation reported in this study.
Discussion
This study investigated the immediate effect of six dif-
ferent topical analgesic creams on pressure pain thresh-
old at a single trapezius MTrP and on bilateral cervical
lateral flexions. We found that the topical analgesics
BG, PTMC roll-on and MM cream demonstrated signif-
icant and clinically important increases in pressure
threshold when comparing short-term MTrP tenderness.
In addition, PTMC roll-on was better than placebo and
I c yH o tE x t r aS t r e n g t hC r e am in reducing short-term
MTrP tenderness. BG was better than placebo at redu-
cing short-term MTrP tenderness.
Figure 1 (a) Range of motion, (b) pressure algometry, and (c) topical application.
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cantly increase in right or left lateral flexion.
The effectiveness of the topical analgesics that showed
clinically significant improvements in cervical spine
pressure threshold may be due to several factors. Euca-
lyptus oil, that was found in the PTMC solution, has
been shown to transport active ingredients deep into the
subcutaneous tissues [28,29]. Camphor and menthol,
found in both BG and PTMC, have been proven to pro-
vide immediate pain relief [19,30,31]. Glucosamine sul-
fate, chondroitin sulfate, dimethyl sulfoxide and
Boswellia serrata extract, found in the PTMC roll-on
formulation, have been shown to improve circulation
and reduce inflammation, thus reducing pain in the
short-term [19,32,33]. In addition, magnesium chloride,
which is unique to the PTMC roll-on, has been shown
to be effectively absorbed through the dermis into mus-
cle [34,35].
Topical analgesics are typically easy to self-apply.
While this is a feature of many non-pharmacologic topi-
cals, evidence of the effectiveness of the topical analge-
sics tested in this study is significantly lacking in the
research literature. The results from the study demon-
strate promising results for patients with myofascial
pain. Since the topical analgesics are easy to use, they
may improve the patients’ self-care through increased
compliance and help alleviate the painful symptoms
they experience from MTrPs.
Many clinicians use these topical analgesics during
multiple sessions or in combination with other proven
therapies. Many clinicians theorize that the combination
therapy or multiple session uses will result in long-term
benefits. The intervention in this study was applied in
one single session with only short-term outcomes mea-
sured. A similar study has been published on the out-
comes from a single manual therapy session for patients
with neck pain [36]. A clinical prediction rule has been
formulated for single-session response to manual ther-
apy for neck pain. Our findings show similar benefits
compared with the manual therapy neck pain study and
provides support for further research. Future studies
with multiple sessions over several treatment days or in
combination with other therapies are needed to validate
the effects of the topical analgesics commonly used in
clinical settings.
Limitations
This study used participants with and without cervical
spine and trapezius pain. This may have attenuated the
outcomes measured in this study. Future research
should separately evaluate pain and non-painful groups
to eliminate any confounding factors.
Table 1 Group demographics and clinical baseline values
Variable Group
A
Group
B
Group
C
Group
D
Group
E
Group
F
Statistic
AGE 48.5
(17.7)
48.5
(14.7)
47.9
(15.1)
47.1
(14.7)
45.0
(12.5)
51.1
(15)
NS
F = 0.3
p = 0.89
GENDER M = 8
F=1 2
M=8
F=1 2
M=1 1
F=9
M=1 1
F=9
M=1 1
F=9
M=7
F=1 3
NS CSq = 4.0, p = 0.97
NECK and SHOULDER PAIN Y = 11
N9
Y=1 2
N=8
Y=1 1
N=9
Y=1 0
N=1 0
Y=1 2
N=8
Y=1 1
N=9
NS CSq = 2.2, p = 0.99
Pressure Pain Threshold (kg/in
2) 4.5
(2.2)
4.6
(1.5)
4.9
(2.4)
4.2
(1.3)
4.1
(0.9)
4.5
(2.4)
NS
F = 0.41
p = 0.83
Table 2 Pressure pain thresholds.
Group Pre-Tx
(kg/cm
2)
Post-Tx
(kg/cm
2)
Change
(kg/cm
2)
Intra-group
Significance
Inter-group
Significance*
A 4.5 (+/-0.48) 5.0 (+/-0.56) 0.5 (+/-0.15) p = 0.002 A > C (p = 0.0003)
B 4.6 (+/-0.33) 4.5 (+/-0.35) -0.45 (.12) p = 0.37 NS
C 4.9 (+/-0.53) 4.6 (+/-0.54) -0.3 (+/-0.19) p = 0.067 NS
D 4.2 (+/-0.28) 4.96 (+/-0.39) 0.72 (+/-0.17) p = 0.0002 D > C (p = 0.002)
D > E (p = 0.006)
E 4.1 (+/-0.20) 4.4 (+/-0.32) 0.35 (+/-0.23) p = 0.07 NS
F 4.4 (+/-0.55) 4.9 (+/-0.59) 0.47 (+/-0.19) p = 0.01
A = Bengay Ultra Strength Muscle Pain ointment, B = Biofreeze roll-on gel, C = Placebo, D = Professional Therapy Muscle Care roll-on, E = Icy Hot Extra Strength
Cream, F = Motion Medicine
*Bonferroni corrected p value = 0.007
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ence, nor, was prior experience measured as an explana-
tory variable. However, our efforts to blind subjects to
the nature of the topicals used should have reduced the
effect of any prior treatment experience.
Only one trial of pressure algometery and cervical
ranges of motion was obtained pre-post intervention for
each patient. As there is likely to be some variability
with examiner testing, multiple recordings should be
obtained in future studies.
It is unknown if any of the significant results obtained
immediately post-intervention would be sustained over a
longer period of time. Future studies should measure
longer term outcome measures, such as a few hours
after treatment.
Conclusions
This study demonstrated that some topical analgesic
products do reduce myofascial pain or tenderness. The
results of this study demonstrated that there were clini-
cally important and significant differences between the
topical analgesics tested. The BG, MM and the PTMC
roll-on ointment demonstrated significant increases in
pressure threshold levels. PTMC roll-on and BG were
significantly superior to the placebo in the short-term
reduction of myofascial tenderness. Furthermore, the
PTMC roll-on demonstrated that it was significantly
superior to the IH in the short-term reduction of myo-
fascial tenderness.
There were no significant differences in range of
motion testing for any of the topical analgesics. Future
studies are needed to evaluate the effect of topical
analgesics on the duration of effects of topical pain
relief.
Endnotes
aProfessional Therapy Muscle Care
® Extra Strength Pain
Relief Roll-on, Muscle Care Products (div. of Active &
Innovative Inc.) Toronto, ON M4T 2V7
bMM Cream, Motion Medicine Inc., Calgary, AB T2Y
2Z7
cBengay Ultra Strength Muscle Pain non-greasy, non-
staining cream, Johnson & Johnson Inc. Markham, ON
L3R 5L2, Canada.
eIcy Hot Extra Strength Pain Relieving Cream, Chat-
tem Canada, Mississauga, ON L5N 2K7, Canada
fBiofreeze Pain Relieving Roll-on Gel with Ilex, Royal
Cross, Concord, ON L4K 2L9, Canada
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